Prevalence of psychotropic drug use among elderly Icelanders living at home;Algengi gelyfjanotkunar eldri Íslendinga utan stofnana

Laeknabladid

Volumn 95, Issue 1, 2009, Pages 11-17

  Samúelsson, Ólafur ^a   Zoëga, Helga ^a   Gumundsson, Aalsteinn ^a   Halldórsson, Matthías ^a  

^a Öldrunarsvii Landspítala ^*  (Iceland)

Author keywords

Drug use; Elderly; Iceland; Prevalence; Psychotropics

Indexed keywords

PSYCHOTROPIC AGENT;

AGE; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL PRACTICE; COMPARATIVE STUDY; DAILY LIFE ACTIVITY; DENMARK; DRUG UTILIZATION; ELDERLY CARE; EPIDEMIOLOGY; FEMALE; HUMAN; ICELAND; MALE; PRESCRIPTION; REGISTER; SEX DIFFERENCE;

ACTIVITIES OF DAILY LIVING; AGE DISTRIBUTION; AGE FACTORS; AGED; DENMARK; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; HEALTH CARE SURVEYS; HEALTH SERVICES FOR THE AGED; HUMANS; ICELAND; MALE; PHYSICIAN'S PRACTICE PATTERNS; PSYCHOTROPIC DRUGS; REGISTRIES; SEX FACTORS;

EID: 61549096563     PISSN: 00237213     EISSN: 16704959     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Shah RR. Drug development and use in the elderly: Search for the right dose and dosing regimen. Br J Clin Pharmacol 2004; 58: 452-469
2. Jyrkka J, Vartiainen L, Hartikainen S, et al. Increasing use of medicines in elderly persons: a five-year follow-up of the Kuopio 75+ Study. Eur J Clin Pharmacol 2006; 62: 151-158
3. Medicines consumption in the Nordic Countries 1999-2003: Nordic Medico Statistical Committee (NOMESCO)2004.
4. Wettermark B, Hammar N, Ford CM, et al. The New Swedish Prescribed Drug Register - Opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol and Drug Saf 2007; 16: 726-735
5. Indikatorer för utvärdering av kvaliteten I alders läkemedelsterapi: Svenska Socialstyrelsen 2003.
6. Lernfelt B, Samuelsson O, Skoog I, Landahl S. Changes in drug treatment in the elderly between 1971 and 2000. Eur C Pharmacol 2003; 59: 637-643
7. Gurwitz JH, Field TS, Harrold LR, et.al. Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting. JAMA 2003; 289: 1107-1116
8. Piette JD, Heisler M, Wagner TH. Cost-Related Medication Underuse Among Chronically Ill Adults. Am J Public Health 2004; 94: 1782-1787.
9. Solomon D. Underuse of osteoporosis medications in elderly patients with fractures: American J Med 2003; 115: 398-400. (Pubitemid 37311258)
10. Fialová D, Topinková E, Gambassi G, et al. Potentially Inappropriate Medication Use Among Elderly Home Care Patients in Europe. JAMA 2005; 293: 1348-1358
11. Samúelsson O, Björnsson S, Jóhannsson B, Jónsson PV. Lyfjanotkun aldrara á bráasjú krahúsi: Aukaverkanir og gæavísar. Læknablai 2000; 86: 11-16
12. Giron MS, Forsell Y, Bernsten C, et al. Sleep problems in a very old population: drug use and clinical correlates. J Gerontol A Biol Sci Med Sci 2002; 57: M236-40.
13. Buysse DJ. Insomnia, depression and aging. Assessing sleep and mood interactions in older adults. Geriatrics 2004; 59: 47-51.
14. Skoog I. Psychiatric epidemiology of old age: the H70 study - the NAPE Lecture 2003. Acta Psychiatr Scand 2004; 109: 4-18.
15. Hanlon JT, Schmader KE, Koronkowski MJ, et al.; Adverse drug events in high risk older outpatients. J Am Geriatr Soc 1998; 46: 252-253
16. Moore AR, O'Keeffe ST. Drug-Induced Cognitive Impairment in the Elderly Drugs Aging 1999; 15(1): 15-28.
17. Sigfússon E. Notkun svefnlyfja og róandi lyfja síustu 26 árin. Heilbrigis- og tryggingaráuneyti 2004.
18. Helgason T, Tómasson K, Zoëga T. Algengi og dreifing notkunar gedeyfar-, kvía- og svefnlyfja. Læknablai 2003; 89: 15-22.
19. Sigursson JÁ. Notkun róandi lyfja og svefnlyfja: upplýsingar frá apóteki og úr sjú kraskrám í Egilsstaalæknishérai 1986- 1989. Læknablai 1994; 80: 99-103.
20. Kamel NS. Gammack JK. Insomnia in the elderly: cause, approach, and treatment. Am J Med 2006; 119(6): 463-469
21. Evans ME, Mottram P. Diagnosis of depression in elderly patients. Advances in Psychiatric Treatment 2000; 6: 49-56.
22. Sorock GS and Shimkin EE. Benzodiazepine sedatives and the risk of falling in a community-dwelling elderly cohort. Arch Int Med 1988; 148: 2441-2444
23. Ray A, Griffin MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA 1989; 262: 3303-7..
24. Swift C. Falls in late life and their consequences- implementing effective services. BMJ 2001; 322 : 855-857
25. Campbell AJ, Robertson MC, Gardner MM, et al. Psychotropic medication withdrawal and a home-based exercise program to prevent falls: a randomised, controlled trial. J Am Geriatr Soc 1999; 47 : 850-853
26. Paulose-Ram R, Jonas BC, Orwig D, et al. Prescription psychotropic medication use among the U.S. adult population: results from the third National Health and Nutrition Examination Survey, 1988-1994. J Clin Epidemiol 2003; 57: 309-317
27. Simoni-Wastila L. Gender and Psychotropic Drug Use. Med Care 1998; 36: 88-94.
28. Roe CM, McNamara AM, and Motheral BR. Gender- and agerelated prescription drug use patterns. Anna Pharmacother 2002: 36: 30-39
29. Öppna jämförelser av hälso- och sjukvårdens kvalitet och effektivitet. Jämförelser mellan landsting 2007. Sveriges kommuner och landsting. Stockholm 2007.
30. Hayes B, Klein-Schwartz W , Barrueto F. Polypharmacy and the Geriatric Patient. Clin Geriatr Med 2007; 23: 371-390
31. Johnell K, Klarin I. The Relationship between Number of Drugs and Potential Drug-Drug Interactions in the Elderly: A Study of Over 600.000 Elderly Patients from the Swedish Prescribed Drug Register. Drug Saf 2007; 30: 911-918
32. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. Arch Int Med 1997; 157: 1531-1536
33. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163: 2716-2724
34. Fastbom J, Claesson CB, Cornelius C, Thorslund M, Winblad B. The use of medicines with anticholinergic effects in older people. J Am Geriatr Soc 1995; 43: 1135-1140
35. Salzman C. Medication compliance in the elderly. J Clin Psychiatry1995; Suppl 1: 18-22.
36. MacLaughlin EJ, Raehl CL, Treadway AK, et al. Assessing medication use in the elderly: Which tools to use in clinical practice. Drugs and Aging 2005; 22: 231-255
37. Ásgeirsson ÁG, Almarsdóttir AB. Umfang og ástæur sóunar lyfja á Íslandi - skil almennings. Rannsóknarstofnun um lyfjamál vi Háskóla Íslands, Reykjavík: 2008.
38. Tybjerg J, Gulmann NC. Use of psychopharmaceuticals in municipal nursing homes. A nationwide survey. Ugeskr Laeger 1992; 154: 3126-3129
39. Hughes CM, Lapane KL, Mor V, et al. The Impact of Legislation on Psychotropic Drug Use in Nursing Homes: A Cross-National Perspective. J Am Geriatr Soc 2000; 48: 931-937